Shilpa Medicare Limited Total Liabilities
Shilpa Medicare Limited total liabilities. Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has total liabilities worth Rs10.57 Billion INR (≈ $114.27 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Shilpa Medicare Limited to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shilpa Medicare Limited (2006–2025)
Total liabilities of Shilpa Medicare Limited from 2006 to 2025. This chart illustrates how Shilpa Medicare Limited's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Shilpa Medicare Limited's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Shilpa Medicare Limited Competitors by Total Liabilities
The table below lists competitors of Shilpa Medicare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shandong Iron and Steel Co Ltd
SHG:600022
|
China | CN¥53.23 Billion |
|
Malaysian Pacific Industries
KLSE:3867
|
Malaysia | RM956.47 Million |
|
Appian Corp
NASDAQ:APPN
|
USA | $690.89 Million |
|
Henan Yuneng Holdings Co Ltd
SHE:001896
|
China | CN¥28.64 Billion |
|
Albany International Corporation
NYSE:AIN
|
USA | $1.00 Billion |
|
Union Semiconductor (Hefei) Co. Ltd. A
SHG:688403
|
China | CN¥1.02 Billion |
|
Plug Power Inc
NASDAQ:PLUG
|
USA | $1.61 Billion |
|
Sinocelltech Group Ltd
SHG:688520
|
China | CN¥4.49 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Shilpa Medicare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SHILPAMED total asset value.
Liquidity & Leverage Metrics
Shilpa Medicare Limited Total Liabilities Ratios Explained
Shilpa Medicare Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shilpa Medicare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shilpa Medicare Limited (2006–2025)
The table below shows the annual total liabilities of Shilpa Medicare Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs9.47 Billion ≈ $102.42 Million |
-26.77% |
| 2024-03-31 | Rs12.93 Billion ≈ $139.86 Million |
+14.49% |
| 2023-03-31 | Rs11.30 Billion ≈ $122.16 Million |
+6.13% |
| 2022-03-31 | Rs10.64 Billion ≈ $115.11 Million |
-9.03% |
| 2021-03-31 | Rs11.70 Billion ≈ $126.54 Million |
+75.22% |
| 2020-03-31 | Rs6.68 Billion ≈ $72.21 Million |
+58.97% |
| 2019-03-31 | Rs4.20 Billion ≈ $45.43 Million |
+0.18% |
| 2018-03-31 | Rs4.19 Billion ≈ $45.35 Million |
-9.24% |
| 2017-03-31 | Rs4.62 Billion ≈ $49.96 Million |
+47.27% |
| 2016-03-31 | Rs3.14 Billion ≈ $33.93 Million |
-8.60% |
| 2015-03-31 | Rs3.43 Billion ≈ $37.12 Million |
+26.48% |
| 2014-03-31 | Rs2.71 Billion ≈ $29.35 Million |
+22.09% |
| 2013-03-31 | Rs2.22 Billion ≈ $24.04 Million |
+45.98% |
| 2012-03-31 | Rs1.52 Billion ≈ $16.47 Million |
+35.88% |
| 2011-03-31 | Rs1.12 Billion ≈ $12.12 Million |
-29.75% |
| 2010-03-31 | Rs1.60 Billion ≈ $17.25 Million |
-1.46% |
| 2009-03-31 | Rs1.62 Billion ≈ $17.51 Million |
+30.03% |
| 2008-03-31 | Rs1.24 Billion ≈ $13.46 Million |
+455.31% |
| 2007-03-31 | Rs224.19 Million ≈ $2.42 Million |
+116.46% |
| 2006-03-31 | Rs103.57 Million ≈ $1.12 Million |
-- |
About Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, … Read more